BioSpace News Archive

Molecular Imaging Devices Market Size, Outlook and Growth Opportunities 2024

Molecular imaging is a breakthrough technology that was introduced to the medical diagnostics world in the early 21st century.

January 28, 2022
·
5 min read
Neuroendovascular Coil Market: High Incidence of Brain Aneurysms is Expected to Drive the Market

Neuroendovascular coiling is performed to prevent the blood flow in an aneurysm. An aneurysm is the excessive enlargement of blood vessels lead to a weakness of the blood vessel wall.

January 28, 2022
·
5 min read
Genetown

Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner

Oxford Biomedica plc, a leading gene and cell therapy group, and Homology Medicines, Inc., a genetic medicines company, announced that the companies have agreed to establish a high-performing, full scope Adeno-Associated Virus Manufacturing and Innovation Business in the U.S.

January 28, 2022
·
14 min read
Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

Royal Philips, a global leader in health technology, and the University Hospital Brandenburg an der Havel have signed a 10-year strategic partnership to renew and expand the hospital’s diagnostic and therapy options through the delivery of advanced technology solutions.

January 28, 2022
·
4 min read
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent Application for Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company is pleased to announce that it has received a Notice of Allowance from the Canadian Patent Office for patent application No. 3101853 entitled: Compositions and Methods for Treating Idiopathic Pulmonary Fibrosis.

January 28, 2022
·
4 min read
Policy

Amryt Announces Oleogel-S10 EMA Regulatory Update

Amryt Announces Oleogel-S10 EMA Regulatory Update.

January 28, 2022
·
6 min read
Business

Regeneron and Sanofi Provide Regulatory Update on Libtayo® (cemiplimab-rwlc) in Advanced Cervical Cancer

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the voluntary withdrawal of the supplemental Biologics License Application (sBLA) for Libtayo ® (cemiplimab-rwlc) as a second-line treatment for patients with advanced cervical cancer.

January 28, 2022
·
18 min read
Pharm Country

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B.

January 28, 2022
·
17 min read
Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano , focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II.

January 28, 2022
·
4 min read
Business

HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors

HTG Molecular Diagnostics, Inc. announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors.

January 28, 2022
·
4 min read